Rheumnow Podcast

934 Episodo

1. We've Got to Talk about CAR T cells

   Publicado: 14/6/2024
2. EULAR 2024 Daily Podcasts Day1&2

   Publicado: 13/6/2024
3. Predicting Palindromic Prognosis

   Publicado: 13/6/2024
4. A Step Closer to Identifying Phenotypes of RA ILD

   Publicado: 13/6/2024
5. Top 3 Messages About JAK Inhibitor Safety

   Publicado: 13/6/2024
6. Pain in RA: Different Drugs for Different Mechanisms

   Publicado: 13/6/2024
7. Giant Cell Arteritis and Polymyalgia Rheumatica Update

   Publicado: 13/6/2024
8. JAK Inhibitors for New Indications

   Publicado: 13/6/2024
9. Top 3 Messages About JAK Inhibitor Safety

   Publicado: 13/6/2024
10. Pain in RA: Different Drugs for Different Mechanisms

    Publicado: 13/6/2024
11. JAK Inhibitors for New Indications

    Publicado: 13/6/2024
12. Potential of Radiomics to Predict TNF Therapy Outcomes in axSpA

    Publicado: 13/6/2024
13. Treat to Target Outcomes in Early AxSpA

    Publicado: 13/6/2024
14. Does Telemonitoring in SpA Work?

    Publicado: 13/6/2024
15. PsA Treatment: is Earlier Better?

    Publicado: 13/6/2024
16. JAK Inhibitors for New Indications

    Publicado: 13/6/2024
17. Transition from Psoriasis to PsA: Can we Prevent It?

    Publicado: 13/6/2024
18. EULAR 2024 Daily Recap - Days 1 & 2

    Publicado: 13/6/2024
19. Mechanistic Promise in RA Doesn’t Always Mean Actual Gain

    Publicado: 13/6/2024
20. The Role of Psychosocial Determinants in the Management of Rheumatoid Arthritis

    Publicado: 13/6/2024